DAHLE MEDICAL HOLDING AS

2619 LILLEHAMMER

Finances

Return on Equity

8,08 %

Current Ratio

3,12

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	103 986 000	121 558 000	124 221 000	98 591 000
Net Income	4 521 000	16 546 000	18 967 000	6 731 000
Total Assets	74 058 000	79 676 000	66 213 000	44 593 000
Total Equity	55 935 000	53 414 000	40 868 000	27 401 000

Income (NOK)	2022	2021	2020	2019
Revenue	103 986 000	121 558 000	124 221 000	98 591 000
Expenditure	98 342 000	100 548 000	100 017 000	90 031 000
Operating Profit	5 644 000	21 010 000	24 204 000	8 560 000
Financial Income	221 000	508 000	733 000	190 000
Financial Costs	69 000	305 000	616 000	118 000
Financial Balance	152 000	203 000	117 000	72 000
Earnings Before Tax	5 796 000	21 214 000	24 320 000	8 632 000
Tax	1 276 000	4 668 000	5 353 000	1 901 000
Net Income	4 521 000	16 546 000	18 967 000	6 731 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	17 594 000	4 921 000	4 236 000	3 704 000
Total Current Assets	56 464 000	74 755 000	61 977 000	40 889 000
Total Assets	74 058 000	79 676 000	66 213 000	44 593 000
Total Retained Equity	0	43 272 000	30 726 000	17 259 000
Total Equity	55 935 000	53 414 000	40 868 000	27 401 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	18 123 000	26 262 000	25 345 000	17 192 000
Total Equity and Debt	74 058 000	79 676 000	66 213 000	44 593 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	103 807 000	121 450 000	124 146 000	98 584 000
Other Income	179 000	108 000	76 000	7 000
Revenue	103 986 000	121 558 000	124 221 000	98 591 000
Cost of Goods Sold	65 850 000	70 180 000	72 423 000	63 503 000
Salary Costs	17 960 000	17 201 000	16 019 000	15 776 000
Depreciation	456 000	435 000	362 000	285 000
Impairment	0	0	0	0
Expenditure	98 342 000	100 548 000	100 017 000	90 031 000
Operating Profit	5 644 000	21 010 000	24 204 000	8 560 000
Financial Income	221 000	508 000	733 000	190 000
Financial Costs	69 000	305 000	616 000	118 000
Financial Balance	152 000	203 000	117 000	72 000
Dividends	2 000 000	4 000 000	5 500 000	1 000 000
Net Income	4 521 000	16 546 000	18 967 000	6 731 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	516 000	649 000	729 000	651 000
Real Eastate	13 364 000	137 000	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	917 000	883 000	807 000	492 000
Total Tangible Assets	14 281 000	1 020 000	807 000	492 000
Total Fiancial Fixed Assets	2 796 000	3 252 000	2 701 000	2 561 000
Total Fixed Assets	17 594 000	4 921 000	4 236 000	3 704 000
Stock	17 602 000	23 451 000	14 036 000	8 576 000
Total Investments	0	0	0	0
Cash, Bank	28 322 000	38 336 000	31 193 000	19 979 000
Total Current Assets	56 464 000	74 755 000	61 977 000	40 889 000
Total Assets	74 058 000	79 676 000	66 213 000	44 593 000
Total Equity	55 935 000	53 414 000	40 868 000	27 401 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	7 326 000	8 656 000	10 022 000	7 870 000
Unpaid Taxes	2 170 000	2 714 000	3 952 000	2 276 000
Dividends	2 000 000	4 000 000	5 500 000	1 000 000
Other Current Debt	5 336 000	8 156 000	3 944 000	4 094 000
Total Current Debt	18 123 000	26 262 000	25 345 000	17 192 000
Total Equity and Debt	74 058 000	79 676 000	66 213 000	44 593 000

Financial indicators	2022	2021	2020	2019
Return on Equity	8,08 %	30,98 %	46,41 %	24,56 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	5,43 %	17,28 %	19,48 %	8,68 %
Current Ratio	3,12	2,85	2,45	2,38
Quick Ratio	108,38	26,59	5,48	4,75
Equity Ratio	0,76	0,67	0,62	0,61
Gross Profit Margin	36,67 %	42,27 %	41,7 %	35,59 %